[EN] OXAZOLE PYRIDINE DERIVATIVES USEFUL AS S1P1 RECEPTOR AGONISTS<br/>[FR] DÉRIVÉS D'OXAZOLE PYRIDINE UTILES EN TANT QU'AGONISTES DU RÉCEPTEUR S1P1
申请人:MERCK SERONO SA
公开号:WO2010100142A1
公开(公告)日:2010-09-10
The present invention provides oxadiazole pyridine derivatives of Formula (I), their use as medicaments and their use for treating multiple sclerosis and other diseases.
本发明提供了式(I)的噁二唑吡啶衍生物,以及它们作为药物的用途,用于治疗多发性硬化症和其他疾病。
OXAZOLE PYRIDINE DERIVATIVES USEFUL AS S1P1 RECEPTOR AGONISTS
申请人:Quattropani Anna
公开号:US20110306636A1
公开(公告)日:2011-12-15
The present invention provides oxadiazole pyridine derivatives of Formula (I), their use as medicaments and their use for treating multiple sclerosis and other diseases.
本发明提供了式(I)的噁唑吡啶衍生物,其用作药物治疗多发性硬化症和其他疾病。
HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
申请人:CHDI Foundation, Inc.
公开号:US20190202795A1
公开(公告)日:2019-07-04
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.